As mentioned earlier, elevated IGF2 mRNA expression correlated with shorter survival in HCC, was associated with a switch from normal liver‐specific promoter P1 to the fetal P3 promoter in the IGF2 gene, and was inversely correlated with SRSF3 mRNA levels. This evidence concerns the gene IGF2 and hepatocellular carcinoma.